Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
Eli Lilly’s $3.2 Billion Acquisition of Morphic Holdings
Robinhood’s Acquisition of Pluto
Fenwick & West represented Robinhood in the transaction. Robinhood Markets, Inc. (Robinhood), a financial services platform, announced its acquisition of Pluto Capital Inc. (Pluto), an AI-powered...
Incyte’s $750 Million Acquisition of Escient Pharmaceuticals
Fenwick & West is advising Escient Pharmaceuticals on the transaction, and Covington & Burling is advising Incyte. Incyte (Nasdaq:INCY) announced the acquisition of Escient Pharmaceuticals (“Escient”). Incyte...
Vertex Pharmaceuticals’ Acquisition of Alpine Immune Sciences
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
GitLab’s Acquisition of Oxeye
Fenwick & West represented GitLab, Inc. in the transaction. GitLab, an AI-powered DevSecOps platform, announced its acquisition of Oxeye, a provider of a cloud-native application security...
Veracyte’s Acquisition of C2i Genomics
Fenwick & West is representing Veracyte in the transaction, and Meitar is representing C2i Genomics. Veracyte, Inc. (Nasdaq: VCYT) announced it has entered into a definitive agreement...
Standard BioTools’ Merger with SomaLogic
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
Wonder Group’s $103 Million Acquisition of Blue Apron
Fenwick & West represented Wonder Group in the transaction, and Wilmer Cutler Pickering Hale and Dorr represented Blue Apron Holdings. Wonder Group (“Wonder”) announced that it has...
Eli Lilly’s $2.4 Billion Pending Acquisition of DICE THerapeutics
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
Thoma Bravo and Sunstone Partners’ $1.3 Billion Acquisition of UserTesting
Fenwick represented UserTesting, Kirkland & Ellis represented Thoma Bravo, Goodwin Procter advised Sunstone Partners on the deal. UserTesting, a video-based human insight company, announced its acquisition by...
Idera Pharmaceuticals’ Acquisition of Aceragen
Fenwick represented Aceragen on the deal, Morgan Lewis advised Idera Pharmaceuticals. Aceragen, a privately-held biotechnology company addressing rare, orphan pulmonary and rheumatic diseases for which there...
Muck Rack’s $180 Million Series A Minority Investment
Fenwick represented Muck Rack on the deal. Muck Rack, a Public Relations Management (PRM) platform that helps organizations find the right journalists to pitch, report on...